Key result
Metformin significantly inhibited diabetes-induced blood levels of ROS, left ventricular p53 and collagen expression, glycated haemoglobin, and dyslipidemia in a rat model of T2DM.
Why the study?
The link between ROS, p53, and collagen in T2DM-induced cardiac injury in the presence and absence of metformin had not been previously investigated.
Does metformin prevent ROS-p53 mediated fibrosis and dyslipidemia in a rat model of T2DM-induced left ventricular injury?
Does metformin prevent ROS-p53 mediated fibrosis and dyslipidemia in a rat model of T2DM-induced left ventricular injury?
In a rat model of T2DM, metformin protected against diabetic cardiomyopathy-induced fibrosis and dyslipidemia by modulating the ROS-p53-collagen axis.
Answers are grounded in this paper and cite their sources.
Supports mechanistic research on metformin in diabetic cardiomyopathy; leaves open translation to human T2DM.
BACKGROUND: The link between oxidative stress (ROS), apoptosis (p53) and fibrosis (collagen) in type 2 diabetes mellitus (T2DM)-induced cardiac injury in the presence and absence of the antidiabetic drug, metformin has not been investigated before. MATERIAL AND METHODS: T2DM was induced in rats by a combination of high carbohydrate and fat diets (HCFD) and streptozotocin (50 mg/kg) injection. The protection group started metformin (200 mg/kg) treatment 14 days prior to the induction of diabetes and continued on metformin and HCFD until being sacrificed at week 12. RESULTS: Diabetes significantly induced blood levels of ROS and left ventricular p53 and collagen expression that was inhibited by metformin. Metformin also significantly reduced glycated haemoglobin and dyslipidemia induced by diabetes. In addition, a significant correlation between ROS-p53-collagen axis and glycaemia and hyperlipidaemia was observed. CONCLUSIONS: These findings show that metformin provides substantial protection against diabetic cardiomyopathy-induced ROS-p53 mediated fibrosis and dyslipidemia.
No takes yet. Share an insight, caveat, or question.
Al‐Ani et al. (2021) studied Type 2 diabetes mellitus-induced left ventricular injury. Metformin vs. Diabetic rats without metformin was evaluated on Blood levels of ROS, left ventricular p53 and collagen expression, glycated haemoglobin, and dyslipidemia. Metformin significantly inhibited diabetes-induced blood levels of ROS, left ventricular p53 and collagen expression, glycated haemoglobin, and dyslipidemia in a rat model of T2DM.
Synapse has enriched 10 related papers. Consider them for comparative context: